Sujal Shah - Chief Executive Officer, Director at CymaBay Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
CBAY
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sujal Shah - trading volume in the past year for CymaBay Therapeutics, Inc.

Holdings reported by Sujal Shah for CymaBay Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $2.94 Mar 22, 2024 Direct
Stock Appreciation Right 0 Dec 11, 2023 Direct Common Stock
Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct Common Stock

Transactions reported by Sujal Shah for CymaBay Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.